SCHEMBL3506565

SCHEMBL3506565

COCC1OCN(c2ccc3nc(C=CCC#N)sc3c2)C1=O

nearest known ligand 0.33

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
CLK1 P49759 2/20 0.31
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31
APP P05067 1/20 0.30
SNCA P37840 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3506563 0.83 GRM2 (0.38)
SCHEMBL3506560 0.83 GRM2 (0.38)
SCHEMBL3505525 0.82 LIPG (0.35) CLK1MEN1KMT2A
SCHEMBL3505103 0.80 DRD2 (0.34) MEN1KMT2A
SCHEMBL3504925 0.80 DRD2 (0.34) MEN1KMT2A
SCHEMBL3505662 0.80 DRD2 (0.34) MEN1KMT2A
SCHEMBL3505070 0.80 DRD2 (0.34) MEN1KMT2A
SCHEMBL3506627 0.80 DRD2 (0.34) MEN1KMT2A
SCHEMBL3503416 0.80 DRD2 (0.34) MEN1KMT2A
SCHEMBL3505527 0.79

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5475014-A Monoamine oxidase inhibor; antidepressant EISAI CO., LTD. (JP) 1995-12-12 US claimed
US-20100247543-A1 TREATMENT AND PREVENTION OF NEURODEGENERATIVE DISEASES ORYZON GENOMICS, S.A. (ES) 2010-09-30 US disclosed